10 Recruiting Extensive Stage Lung Small Cell Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for extensive stage lung small cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Extensive Stage Lung Small Cell Carcinoma studiesPhase 2 Studies for Extensive Stage Lung Small Cell Carcinoma
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
📍 Loma Linda University Medical Center — Loma Linda, California
View Study & Checklist ➔